vialroom

#tirzepatide 2026-05-19

Tuesday42 messages8 participantstimes are UTC
Highlights from this day
  • step_one_sian — dual agonist, GIP as well as GLP-1, thats the whole difference in one line 22:54
  • two_three_lifts — i went to 15 and came back to 10, more suppression wasnt more useful for me 23:08
  • two_three_lifts — my Janoshik result on a MKM vial came in at 98.6 which is why i keep buying from them, happy to be corrected 23:15

while im here the trials titrated every four weeks to a target, most people here stop at whatever works

at 15 the GI came back for me, so my easier profile claim only applies below that

GIP plus GLP-1

❤️12👀4🤝1
SO

while im here 40 units of a 4 solution is a lot of volume and i check that one twice every single time

MP

does the GIP arm actually explain the easier nausea or is that hand waving

5 did nothing

is 7.5 really the sweet spot or is that just channel folklore

😂3🧊3

SURMOUNT-OSA was the sleep apnoea trial and it is not a weight headline however its quoted

is there a reason to titrate slower than the four week schedule

SO

5 was where i first noticed it properly, 2.5 did almost nothing for me

does the appetite effect feel different or just stronger

i argued the sweet spot was nonsense and then spent 26 months at 7.5 not needing more

dual agonist, GIP as well as GLP-1, thats the whole difference in one line

❤️9💀8
VO

the two compounds arent interchangeable week for week even if the effect ends up similar

SO

the sweet spot argument is really about effect per side effect, not a magic number

VO

update on the earlier thing SURMOUNT was the weight programme and SURPASS was diabetes, thats the split people mix up

chromatogram-overlay.png
1240 × 720 · 404 KB · not retained in the public archive

7.5 gang

for the archive how long before the dual thing was noticeable to you

i went to 15 and came back to 10, more suppression wasnt more useful for me

[edited]
Cited study
Tirzepatide for Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA)
New England Journal of Medicine · 2024
AHI as the primary endpoint, with and without PAP therapy.
🧊3🔥1📉5

held 10 for 7 months and lost 25kg over that stretch, slow and boring and fine

12📈1
CO

at 2 my appetite went completely and i dropped back a step, eating nothing isnt a win

TT

my Janoshik result on a MKM vial came in at 98.6 which is why i keep buying from them, happy to be corrected

[edited]
Trial scheduleWhat most people here do
Step interval4 weeks, fixed4-12 weeks, on symptoms
Holdingprotocol deviationnormal and expected
Top dosereached by designoften never reached
Coming downnot studiedcommon at maintenance

*Janoshik not the other one

VB

Batch lookup E-2205: 9 independent reports on file, earliest 2025-12-28.

CO

plateaued at 17 weeks the same way i did on semaglutide, so i doubt its compound specific

CV

restarted at 2.5 after 15 months off and the first two doses reminded me why titration exists

folklore probably

GI was noticeably easier for me than semaglutide at what felt like the same appetite effect

there is no clean conversion between the two, anyone giving you a ratio is guessing

€120 for a 10 vial is roughly what ive paid for the last year

II

licensed top is 15 weekly, past that is not a licensed dose and nobody here can tell you what it does

II

switched from 5 semaglutide and started at 2.5, took the slow route, never regretted it

💀2